ROSENBLUM MARK J (Exec VP Finance, Interim CFO) received a stock award from DECOY THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/7/2022ACC: 0001615219-22-000141
Officer· Exec VP Finance, Interim CFO
Since Sep 2019
+7.31K
Net shares
Net buyer
$12.7K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
7.31K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+7.31K
Price / share
$1.73
Trade value
$12.68K
% of position
4.9%
11/3/2022
148.32K→155.63K
Total
Net shares
+7.31K
Net value
$12.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/3/2022 | A · Award | +7.31K | $1.73 | $12.68K | 4.9% | 148.32K | 155.63K |
| Total | +7.31K | $12.68K | ||||||
Derivative Transactions0
No derivative transactions reported